Certara stock.

Complete Certara Inc. stock information by Barron's. View real-time CERT stock price and news, along with industry-best analysis. A. The latest price target for Certara ( NASDAQ: CERT) was reported by Stephens & Co. on Wednesday, October 11, 2023. The analyst firm set a price target for 20.00 expecting CERT to rise to within ...Certara share price went down by -16.68% last month. The next quarterly earnings date for Certara is scheduled on November 7, 2023. Certara's next ex-dividend date is August 20, 2023.SOLO | Complete Electrameccanica Vehicles Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Certara has launched a series of interactive educational webinars to teach users how to build PK and PK/PD models in Phoenix. This series is called the Phoenix Modeling Language School or PML School. The series will cover scenarios such as simultaneous fitting of IV and PO data, target-mediated drug disposition, enterohepatic recirculation ...

Avatar has made over 8 trades of the Certara stock since 2020, according to the Form 4 filled with the SEC. Most recently Avatar sold 29,954,521 units of CERT stock worth $449,317,815 on 8 December 2022.

PRINCETON, NJ.—. December 3, 2020 – Certara, Inc. (“Certara”) today announced the launch of its initial public offering of 24,390,000 million shares of its common stock pursuant to a registration statement filed with the Securities and Exchange Commission. Certara is offering 14,630,000 shares of common stock and certain selling ...PRINCETON, N.J., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced it has successfully supported 300 completed submissions to ...

If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up to date on the world markets.Certara, Inc. (CERT) came out with quarterly earnings of $0.11 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.10 per share a year ago. These figures are ...According to 7 stock analysts, the average 12-month stock price forecast for Certara stock is $50.29, which predicts an increase of 240.60%. The lowest target is $16 and the highest is $235. On average, analysts rate Certara stock as a buy.According to the issued ratings of 8 analysts in the last year, the consensus rating for Certara stock is Hold based on the current 5 hold ratings and 3 buy ratings for CERT. The average twelve-month price prediction for Certara is $19.71 with a high price target of $24.00 and a low price target of $16.00. Learn more on CERT's analyst rating ...

November 15, 2021. PRINCETON, N.J.– November 15, 2021– Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced a proposed underwritten public offering by certain selling stockholders of 10 million shares of its common stock pursuant to a registration statement filed with the Securities and Exchange Commission.

Find the latest Canoo Inc. (GOEV) stock quote, history, news and other vital information to help you with your stock trading and investing.

The estimated Net Worth of William F Feehery is at least $75.5 million dollars as of 31 March 2023. Dr Feehery owns over 36,580 units of Certara stock worth over $42,281,189 and over the last 11 years he sold CERT stock worth over $31,782,752. In addition, he makes $1,387,564 as CEO & Director at Certara.PRINCETON, N.J., Nov. 21, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the introduction of Simcyp™ Biopharmaceutics software. It is ...Certara, Inc. (CERT) delivered earnings and revenue surprises of 0% and 1.14%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?Josh Xie is Director-Clinical Pharmacology at Certara, Inc. ... Stock quotes are provided by Factset, Morningstar and S&P Capital IQ Stock markets for all 100% Free Registration. 100% Free RegistrationCertara, Inc. is a provider of biosimulation software and technology-enabled services. The Company is focused on producing medicines for patients using biosimulation software, technology, and services to transform traditional drug discovery and development.Certara, Inc. (NASDAQ:CERT), is not the largest company out there, but it received a lot of attention from a substantial price movement on the NASDAQGS over the last few months, increasing to US ...Robert Aspbury CERT stock SEC Form 4 insiders trading. Robert has made over 7 trades of the Certara stock since 2021, according to the Form 4 filled with the SEC. Most recently Robert exercised 8,646 units of CERT stock worth $211,049 on 31 March 2023.8,646 units of CERT stock worth $211,049 on 31 March 2023.

From Nasdaq : Certara, which provides biosimulation software and services used for drug development, filed on Wednesday with the SEC to raise up to $100 million in an initial public offering. However, this is likely a placeholder for a deal we estimate could raise up to $500 million. The company uses its biosimulation software and technology to ...Real time Certara (CERT) stock price quote, stock graph, news & analysis.Nov 21, 2023 · PRINCETON, N.J., Nov. 21, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the introduction of Simcyp™ Biopharmaceutics software. It is ... 8 brokerages have issued 1 year price objectives for Certara's stock. Their CERT share price targets range from $16.00 to $24.00. On average, they expect the company's share price to reach $19.71 in the next twelve months. This suggests a possible upside of 31.7% from the stock's current price.View the latest Corteva Inc. (CTVA) stock price, news, historical charts, analyst ratings and financial information from WSJ.PRINCETON, N.J., November 17, 2021. — Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the pricing of its underwritten public …Complete Certara Inc. stock information by Barron's. View real-time CERT stock price and news, along with industry-best analysis.

Drayton Virkler CERT stock SEC Form 4 insiders trading. Drayton has made over 2 trades of the Certara stock since 2022, according to the Form 4 filled with the SEC. Most recently Drayton exercised 3,990 units of CERT stock worth $54,863 on 31 March 2023.3,990 units of CERT stock worth $54,863 on 31 March 2023.0.68%. $788.96M. Frontage Holdings Corp. -0.47%. HK$4.39B. CERT | Complete Certara Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full …

Certara, Inc. (CERT) delivered earnings and revenue surprises of 14.29% and 4.34%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?Mar 22, 2023 · Reiterating 2023 Financial Outlook. Certara continues to expect the following: Full year 2023 revenue to be in the range of $370 million to $385 million. Full year 2023 adjusted EBITDA to be in the range of $131 million to $137 million. Full year adjusted diluted earnings per share to be in the range of $0.50 - $0.55. Feb 2, 2022 · Certara went public in December 2020, raising $337 million in an IPO. The firm sells biosimulation software and related services to biopharmaceutical firms and regulatory agencies worldwide. CERT ... CHPT | Complete ChargePoint Holdings Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.New metrics and analytics capabilities enable informed decision making for biopharmaceutical clientsPRINCETON, N.J., Dec. 13, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader ...PRINCETON, N.J., Nov. 17, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the pricing of its underwritten public offering of 10 million shares of its common stock by certain existing stockholders (the “selling stockholders”) at a price to the public of $31.00 per share.OPKO Health Inc. 1.53. +0.07. +4.79%. Get Certara Inc (CERT:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.Certara accelerates medicines using proprietary biosimulation software, technology and services to transform traditional drug discovery and development. Its clients include more than 2,000 biopharmaceutical companies, academic institutions and regulatory agencies across 62 countries.

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

13 Sep 2023 ... On the day of the insider's recent sell, shares of Certara Inc were trading for $14.6 apiece, giving the company a market cap of $2.296 billion.

Arena Pharmaceuticals. 22-Feb-1999. Later Stage VC. 0000. Completed. 5 buyers. To view Certara’s complete exits history, request access ». Information on stock, financials, earnings, subsidiaries, investors, and executives for Certara. Use the PitchBook Platform to explore the full profile. View the latest Corteva Inc. (CTVA) stock price, news, historical charts, analyst ratings and financial information from WSJ.The company showed -9% earnings growth last quarter, while sales growth came in at 15%. Keep an eye out for the company's next round of numbers on or around Mar. 1. The company earns the No. 3 ...Aug 11, 2022 · In connection with the offering, the Selling Stockholders have granted the underwriter a 30-day option to purchase up to 1,050,000 additional shares. No shares are being sold by Certara. The Selling Stockholders will receive all of the proceeds from this offering. The last reported sale price of Certara’s common stock on August 11, 2022 was ... OPKO Health Inc. 1.53. +0.07. +4.79%. Get Certara Inc (CERT:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.The estimated Net Worth of Richard M. Traynor is at least $8.76 Million dollars as of 11 May 2023. Mr Traynor owns over 5,000 units of Certara stock worth over $2,938,988 and over the last 3 years he sold CERT stock worth over $5,825,760.At closing, equity holders of Pinnacle 21 received approximately $250 million in cash consideration and 2,239,717 shares of Certara restricted common stock, subject to certain customary closing adjustments. The transaction is expected to be accretive to Certara’s revenue, revenue growth, and adjusted EBITDA.PRINCETON, N.J., Nov. 21, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the introduction of Simcyp™ Biopharmaceutics software. It is ...GOEV | Complete Canoo Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Mar 22, 2023 · Reiterating 2023 Financial Outlook. Certara continues to expect the following: Full year 2023 revenue to be in the range of $370 million to $385 million. Full year 2023 adjusted EBITDA to be in the range of $131 million to $137 million. Full year adjusted diluted earnings per share to be in the range of $0.50 - $0.55. Dec 1, 2023 · Certara, Inc. (CERT) is a biosimulation software company that provides products and services for drug discovery and development. The stock price, quote, news, and analysis of CERT are updated daily on this web page. See the latest financial performance, earnings, dividends, and ratings of CERT. Nov 10, 2023 · Certara Inc’s Stock Price as of Market Close. As of November 10, 2023, 4:00 PM, CST, Certara Inc’s stock price was $13.50. Certara Inc is up 6.72% from its previous closing price of $12.65. During the last market session, Certara Inc’s stock traded between $12.61 and $13.36. Currently, there are 159.17 million shares of Certara Inc stock ... Analyst Price Forecast Suggests 35.97% Upside. As of October 4, 2023, the average one-year price target for Certara is 19.53. The forecasts range from a low of 16.16 to a high of $25.20. The ...Instagram:https://instagram. best trading platform for futuresuk brokerscheap stocks with high dividendsringcentral price Matthew Walsh CERT stock SEC Form 4 insiders trading. Matthew has made over 12 trades of the Certara stock since 2015, according to the Form 4 filled with the SEC. Most recently Matthew exercised 9,067 units of CERT stock worth $135,642 on 17 May 2023.. The largest trade Matthew's ever made was exercising 102,043 units of … rising stockday trader classes Mar 22, 2023 · Reiterating 2023 Financial Outlook. Certara continues to expect the following: Full year 2023 revenue to be in the range of $370 million to $385 million. Full year 2023 adjusted EBITDA to be in the range of $131 million to $137 million. Full year adjusted diluted earnings per share to be in the range of $0.50 - $0.55. top financial certifications Certara CERT has an Earnings ESP of +5.41% and sports a Zacks Rank #1 at present. You can see the complete list of today’s Zacks #1 Rank stocks here. Certara is set to report its first-quarter ...1.37%. $3.03B. META | Complete Meta Platforms Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Patrick Smith CERT stock SEC Form 4 insiders trading. Patrick has made over 6 trades of the Certara stock since 2022, according to the Form 4 filled with the SEC. Most recently Patrick sold 19,104 units of CERT stock worth $411,691 on 5 June 2023.19,104 units of CERT stock worth $411,691 on 5 June 2023.